Time for the Global Rollout of Endoscopic Lung Volume Reduction

Respiration - Tập 90 Số 5 - Trang 430-440 - 2015
Coenraad F.N. Koegelenberg1, Dirk‐Jan Slebos2, Pallav L. Shah3, Johan Theron4, Keertan Dheda5, Brian Allwood4, Felix J.F. Herth6
1Division of Pulmonology, Dept of Medicine, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.
2Groningen Research Institute for Asthma and COPD (GRIAC)
3Univ London Imperial Coll Sci Technol & Med, Imperial College London
4Univ Stellenbosch, Stellenbosch University, Dept Med, Div Pulmonol
5Univ Cape Town, University of Cape Town, Groote Schuur Hosp
6Univ Heidelberg Hosp, Ruprecht Karl University Heidelberg, Pulmonol & Crit Care Med, Thoraxklin

Tóm tắt

Chronic obstructive pulmonary disease remains one of the most common causes of morbidity and mortality globally. The disease is generally managed with pharmacotherapy, as well as guidance about smoking cessation and pulmonary rehabilitation. Endoscopic lung volume reduction (ELVR) has been proposed for the treatment of advanced emphysema, with the aim of obtaining the same clinical and functional advantages of surgical lung volume reduction whilst potentially reducing risks and costs. There is a growing body of evidence that certain well-defined sub-groups of patients with advanced emphysema may benefit from ELVR, provided the selection criteria are met and a systematic approach is followed. ELVR devices, particularly unidirectional valves and coils, are currently being rolled out to many countries outside of the USA and Europe, although very few centres currently have the capacity to correctly evaluate and provide ELVR to prospective candidates. The high cost of these interventions underpins the need for careful patient selection to best identify those who may or may not benefit from ELVR-related procedures. The aim of this review is to provide the practicing pulmonologist with an overview of the practical aspects and current evidence for the use of the various techniques available, and to suggest an evidence-based approach for the appropriate use of these devices, particularly in emerging markets, where there should be a drive to develop and equip key specialised ELVR units.

Từ khóa


Tài liệu tham khảo

10.1183/09031936.06.00025805

10.1159/000350917

10.1056/NEJMoa030287

10.1159/000341171

10.1056/NEJMoa1106955

10.1177/1753465810368553

10.1136/thoraxjnl-2014-205221

10.1159/000369036

10.1016/j.acra.2011.01.011

10.1183/09031936.00161611

10.1164/rccm.201407-1205OC

10.1378/chest.124.3.1073

10.1016/S0140-6736(03)12762-6

10.1186/1471-2466-7-10

10.1056/NEJMoa0900928

10.1183/09031936.00019711

10.1378/chest.11-2886

10.1183/13993003.congress-2015.PA792

10.1097/00128594-200310000-00005

10.1378/chest.11-0730

10.1016/S2213-2600(13)70047-X

10.1159/000362522

10.1111/resp.12435

10.1164/rccm.200810-1639OC

10.1159/000322649

10.1183/09031936.00205614

10.1016/j.athoracsur.2009.06.038

10.1183/09031936.00092411

10.1159/000336239

10.1164/rccm.200712-1832OC

10.1016/j.jtcvs.2007.05.040

10.1016/S0140-6736(11)61050-7

10.1016/j.rmr.2012.09.010

Thông tin
Thông tin xuất bản

Respiration

Tập 90 Số 5

430-440

Thông tin tác giả